Literature DB >> 32810785

T lymphocyte responses to flaviviruses - diverse cell populations affect tendency toward protection and disease.

Luis Alberto Sanchez Vargas1, Anuja Mathew1, Alan L Rothman2.   

Abstract

Dengue virus (DENV), Yellow Fever virus, West Nile virus, Japanese encephalitis virus and Zika virus are medically important flaviviruses transmitted to humans by mosquitoes and circulate in overlapping geographic areas. Cross-reactive immune responses have been demonstrated among the flaviviruses, particularly the four DENV serotypes. The immunological imprint left by a flavivirus infection can therefore have profound effects on the responses to subsequent infections. In this review we summarize recent research focusing on T cell responses to DENV using clinical samples from prospective cohort studies in Asia. These data suggest that durability of different T cell populations after natural infection or vaccination is an important consideration for the outcome of subsequent flavivirus exposures and we argue for continued investigation in the context of longitudinal cohort studies.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32810785      PMCID: PMC7655706          DOI: 10.1016/j.coviro.2020.07.008

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  30 in total

1.  Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes.

Authors:  Maloy M Mangada; Alan L Rothman
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

Review 2.  Humanized mouse models to study human cell-mediated and humoral responses to dengue virus.

Authors:  Anuja Mathew
Journal:  Curr Opin Virol       Date:  2017-08-09       Impact factor: 7.090

3.  Establishment of dengue virus-specific human CD4+ T lymphocyte clones from Percoll-purified T lymphoblasts by stimulation with monoclonal antibody to CD3.

Authors:  J Zivny; I Kurane; F A Ennis
Journal:  J Immunol Methods       Date:  1995-12-15       Impact factor: 2.303

4.  The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes.

Authors:  Daniela Weiskopf; Michael A Angelo; Derek J Bangs; John Sidney; Sinu Paul; Bjoern Peters; Aruna D de Silva; Janet C Lindow; Sean A Diehl; Stephen Whitehead; Anna Durbin; Beth Kirkpatrick; Alessandro Sette
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

5.  Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion.

Authors:  S B Halstead
Journal:  Yale J Biol Med       Date:  1970-04

Review 6.  Mouse models to study dengue virus immunology and pathogenesis.

Authors:  Raphaël M Zellweger; Sujan Shresta
Journal:  Front Immunol       Date:  2014-04-10       Impact factor: 7.561

7.  Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.

Authors:  Anmol Chandele; Jaturong Sewatanon; Sivaram Gunisetty; Mohit Singla; Nattawat Onlamoon; Rama S Akondy; Haydn Thomas Kissick; Kaustuv Nayak; Elluri Seetharami Reddy; Haroon Kalam; Dhiraj Kumar; Anil Verma; HareKrushna Panda; Siyu Wang; Nasikarn Angkasekwinai; Kovit Pattanapanyasat; Kulkanya Chokephaibulkit; Guruprasad R Medigeshi; Rakesh Lodha; Sushil Kabra; Rafi Ahmed; Kaja Murali-Krishna
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

8.  Antibody-dependent enhancement of severe dengue disease in humans.

Authors:  Leah C Katzelnick; Lionel Gresh; M Elizabeth Halloran; Juan Carlos Mercado; Guillermina Kuan; Aubree Gordon; Angel Balmaseda; Eva Harris
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

9.  Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection.

Authors:  Heather Friberg; Coreen M Beaumier; Sangshin Park; Pamela Pazoles; Timothy P Endy; Anuja Mathew; Jeffrey R Currier; Richard G Jarman; Kathryn B Anderson; Steven Hatch; Stephen J Thomas; Alan L Rothman
Journal:  PLoS Negl Trop Dis       Date:  2018-12-17

10.  Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1.

Authors:  Heather Friberg; Luis J Martinez; Leyi Lin; Jason M Blaylock; Rafael A De La Barrera; Alan L Rothman; J Robert Putnak; Kenneth H Eckels; Stephen J Thomas; Richard G Jarman; Jeffrey R Currier
Journal:  mSphere       Date:  2020-01-22       Impact factor: 4.389

View more
  2 in total

1.  Longitudinal Analysis of Dengue Virus-Specific Memory T Cell Responses and Their Association With Clinical Outcome in Subsequent DENV Infection.

Authors:  Luis Alberto Sanchez-Vargas; Kathryn B Anderson; Anon Srikiatkhachorn; Jeffrey R Currier; Heather Friberg; Timothy P Endy; Stefan Fernandez; Anuja Mathew; Alan L Rothman
Journal:  Front Immunol       Date:  2021-07-28       Impact factor: 8.786

Review 2.  Mucosal Vaccination: A Promising Alternative Against Flaviviruses.

Authors:  Rosendo Luria-Pérez; Luis A Sánchez-Vargas; Paola Muñoz-López; Gabriela Mellado-Sánchez
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.